BENLYSTA

Google image searchProduct monograph

Active ingredient

belimumab, 400 MG/VIAL

DIN: 02370069

Dosage form(s): POWDER FOR SOLUTION

Route(s) of administration: INTRAVENOUS

Description: FOR I.V. INFUSION ONLY. 80MG/ML (RECONST.) - 20ML VIAL.

Schedule: Prescription / Schedule D

Company: GLAXOSMITHKLINE INC

Date: 24-AUG-2011

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AG — Monoclonal antibodies (ATC, ATC/DDD)
• L04AG04 — BELIMUMAB (ATC/DDD)

Reference brand drug: Benlysta

External Links for Benlysta

Search on Google

• Benlysta side effects
• Benlysta dosage
• belimumab side effects
• belimumab dosage

Glaxosmithkline Inc

Go to GlaxoSmithKline website to see drug product details. Sometimes you can find benlysta photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.